NASDAQ: ETNB - 89bio, Inc.

Yield per half year: +10.54%
Dividend yield: 0.00%
Sector: Healthcare

Share chart 89bio, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About 89bio, Inc.

89bio, Inc., биофармацевтическая компания клинической стадии, занимается разработкой и коммерциализацией методов лечения заболеваний печени и кардиометаболических заболеваний. Ведущим продуктом компании является пегозафермин, гликопегилированный аналог фактора роста фибробластов 21 для лечения неалкогольного стеатогепатита; и для лечения тяжелой гипертриглицеридемии. 89bio, Inc. была зарегистрирована в 2018 году и имеет штаб-квартиру в Сан-Франциско, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2019-11-11
ISIN US2825591033
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.89bio.com
Цена ао 8.02
Change price per day: 0% (8.02)
Change price per week: -8.13% (8.73)
Change price per month: -13.02% (9.22)
Change price per 3 month: +0.1248% (8.01)
Change price per half year: +10.54% (7.255)
Change price per year: -31.1% (11.64)
Change price per 3 year: +101% (3.99)
Change price per 5 year: -80.8% (41.77)
Change price per year to date: +2.56% (7.82)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.45 9
P/E 0 0
EV/EBITDA -3.22 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -23.85 0
ROE, % -26.51 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1676 10
Total: 7.4

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 404.74 10
Yield EPS, % -91.84 0
Total: 6
More

ETFShare, %Profitability for 1 year, %Dividends, %
Virtus LifeSci Biotech Clinical Trials ETF 0.69833 63.04 0.33
iShares Micro-Cap ETF 0.17387 17.09 1.54048
Direxion Daily S&P Biotech Bull 3x Shares 0.1005 4067.92 0.25924
Future Tech ETF 0.08416 426.34 0.8416
Principal Healthcare Innovators ETF 0.08416 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.07851 28.58 0.8565
Nuveen ESG Small-Cap ETF 0.05995 13.91 1.41019
ProShares Ultra Nasdaq Biotechnology 0.05432 51.7 0.85651
Avantis U.S Small Cap Equity ETF 0.04782 27.77 1.68271
iShares ESG Aware MSCI USA Small-Cap ETF 0.04514 18.09 1.49366
iShares Morningstar Small Cap Value ETF 0.03024 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.03024 201.65 2.50476
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.01811 17.47 1.51433
FlexShares Morningstar US Market Factor Tilt Index Fund 0.01459 21.94 1.69572
ProShares UltraPro Russell2000 0.01434 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01433 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01433 391.25 1.60498
Fidelity MSCI Health Care Index ETF 0.0086 3 1.46057
ProShares Hedge Replication ETF 0.00411 5.92 1.47892
Humankind US Stock ETF 0.0038 18.81 1.99919
Schwab U.S. Broad Market ETF 0.00123 24.86 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00105 17.99 2.19607
iShares Russell 3000 ETF 0.0009 24.83 1.43482
Avantis U.S. Equity ETF 0.00033 23.04 1.59151
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.06241.511.44



Head Job title Payment Year of birth
Mr. Rohan Palekar CEO & Director 990.52k 1966 (59 years)
Mr. Quoc Le-Nguyen Chief Technical Officer 654.44k 1968 (57 years)
Dr. Harry Mansbach M.D. Chief Medical Officer 691.87k 1965 (60 years)
Mr. Ryan Stephen Martins Chief Financial Officer N/A 1979 (46 years)
Ms. Melissa Abel Senior Vice President of Commercial Strategy N/A
Mr. Paul Shin Senior Vice President of R&D Operations N/A
Ms. Annie J. Chang M.B.A. VP of Investor Relations & Corporate Communications N/A
Ms. Amanda Kurihara Vice President of People & Culture N/A
Mr. Francis W. Sarena Chief Operating Officer 1971 (54 years)
Mr. Shiva K. Natarajan CPA Senior Vice President of Finance & Principal Accounting Officer 1966 (59 years)

Address: United States, San Francisco. CA, 142 Sansome Street - open in Google maps, open in Yandex maps
Website: https://www.89bio.com